Genome-wide identification of TCF7L2/TCF4 target miRNAs reveals a role for miR-21 in Wnt-driven epithelial cancer

International Journal of Oncology

Volumn 40, Issue 2, 2012, Pages 519-526

  Lan, Fengming ^a,b,c   Yue, Xiao ^a,b,c,d   Han, Lei ^a,b,c   Shi, Zhendong ^a,b,c   Yang, Yang ^a,b,c   Pu, Peiyu ^a,b,c   Yao, Zhi ^b   Kang, Chunsheng ^a,b,c  

^a Tianjin Neurological Institute   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

catenin TCF4 signaling; miR 21; miRNA; Transcription initiation site

Indexed keywords

BETA CATENIN; MICRORNA 21; TRANSCRIPTION FACTOR 7 LIKE 2; WNT PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CARCINOMA CELL; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; GENE IDENTIFICATION; GENE TARGETING; GENETIC ASSOCIATION; GLIOMA CELL; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TISSUE MICROARRAY; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUCIFERASES, RENILLA; MICRORNAS; NEOPLASMS, GLANDULAR AND EPITHELIAL; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; TRANSCRIPTION, GENETIC; WNT SIGNALING PATHWAY;

EID: 84862908357     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1215     Document Type: Article

References (32)

1. Hatzis P, van der Flier LG, van Driel MA, et al: Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol Cell Biol 28: 2732-27344, 2008.
2. Miravet S, Piedra J, Miro F, Itarte E, Garcia de Herreros A and Dunach M: The transcriptional factor Tcf-4 contains different binding sites for beta-catenin and plakoglobin. J Biol Chem 277: 1884-18891, 2002.
3. Jin T and Liu L: The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Mol Endocrinol 22: 2383-2392, 2008.
4. Segditsas S and Tomlinson I: Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25: 7531-7537, 2006. (Pubitemid 44885752)
5. Ozsolak F, Poling LL, Wang Z, et al: Chromatin structure analyses identify miRNA promoters. Genes Dev 22: 3172-3183, 2008.
6. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
7. Vasudevan S, Tong Y and Steitz JA: Switching from repression to activation: microRNAs can up-regulate translation. Science 318: 1931-1934, 2007.
8. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
9. Cui Q, Yu Z, Purisima EO and Wang E: MicroRNA regulation and interspecific variation of gene expression. Trends Genet 23: 372-375, 2007. (Pubitemid 47088006)
10. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T and Hammond SM: Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20: 2202-2207, 2006.
11. Liu W, Zabirnyk O, Wang H, et al: miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene 29: 4914-4924, 2010.
12. Wang KC, Garmire LX, Young A, et al: Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth. Proc Natl Acad Sci USA 107: 3234-3239, 2010.
13. Fang Y, Shi C, Manduchi E, Civelek M and Davies PF: MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci USA 107: 13450-13455, 2010.
14. Huang H, Xie C, Sun X, Ritchie RP, Zhang J and Chen YE: miR-10a contributes to retinoid acid-induced smooth muscle cell differentiation. J Biol Chem 285: 9383-9389, 2010.
15. Fu X, Han Y, Wu Y, et al: Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis. Eur J Clin Invest (In press).
16. Liu XG, Zhu WY, Huang YY, et al: High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol (In press).
17. Liu C, Li B, Cheng Y, et al: MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3. Int J Biol Sci 7: 347-363, 2011.
18. Gong C, Yao Y, Wang Y, et al: Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer. J Biol Chem 286: 19127-19137, 2011.
19. Tao J, Lu Q, Wu D, et al: microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells. Oncol Rep 25: 1721-1729, 2011.
20. Zhou X, Ren Y, Moore L, et al: Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab Invest 90: 144-155, 2010.
21. Zhou X, Zhang J, Jia Q, et al: Reduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3. Oncol Rep 24: 195-201, 2010.
22. Schetter AJ, Leung SY, Sohn JJ, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436, 2008. (Pubitemid 351185951)
23. Pu P, Zhang Z, Kang C, et al: Downregulation of Wnt2 and betacatenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther 16: 351-361, 2009.
24. Yue X, Lan F, Yang W, et al: Interruption of beta-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells. Brain Res 1366: 27-37, 2010.
25. MacDonald BT, Tamai K and He X: Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26, 2009.
26. Wei W, Chua MS, Grepper S and So SK: Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Mol Cancer 8: 76, 2009.
27. Ying Y and Tao Q: Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers. Epigenetics 4: 307-312, 2009.
28. Rothwell PM, Fowkes FG, Belch JF, et al: Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377: 31-41, 2010.
29. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006. (Pubitemid 43271657)
30. Liu XS, Brutlag DL and Liu JS: An algorithm for finding protein-DNA binding sites with applications to chromatin-immunoprecipitation microarray experiments. Nat Biotechnol 20: 835-839, 2002. (Pubitemid 34836763)
31. Huang K, Zhang JX, Han L, et al: MicroRNA roles in betacatenin pathway. Mol Cancer 9: 252, 2010.
32. Zhang CZ, Zhang JX, Zhang AL, et al: MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer 9: 229, 2010.